Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 14, 2014 - Issue 10
Submit an article Journal homepage
109
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Risk of selected gastrointestinal toxicities in breast cancer patients treated with regimens containing lapatinib; a pooled analysis of randomized controlled studies

Omar Abdel-RahmanClinical Oncology department, Ain Shams University, Lotfy Elsayed street, Cairo, EgyptCorrespondence[email protected]
&
Mona FouadMedical Microbiology and Immunology department, Ain Shams University, Lotfy Elsayed street, Cairo, Egypt
Pages 1229-1242 | Published online: 14 Aug 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Omar Abdel-Rahman, Hesham ElHalawani & Shaimaa Essam-Eldin. (2016) S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines. Expert Opinion on Drug Safety 15:1, pages 5-20.
Read now
Omar Abdel-Rahman, Hesham ElHalawani, Hoda Ahmed & Mahmoud Ellithy. (2015) Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 9:11, pages 1433-1445.
Read now
Omar Abdel-Rahman & Hesham ElHalawani. (2015) Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis. Expert Opinion on Drug Safety 14:10, pages 1495-1506.
Read now

Articles from other publishers (3)

Giuseppe Tridente. 2017. Adverse Events and Oncotargeted Kinase Inhibitors. Adverse Events and Oncotargeted Kinase Inhibitors 243 264 .
Omar Abdel-Rahman & Mona Fouad. (2016) Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting. Future Oncology 12:6, pages 871-879.
Crossref
Omar Abdel-Rahman, Hesham ElHalawani & Mona Fouad. (2015) Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Immunotherapy 7:11, pages 1213-1227.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.